The HORIZON Retinal Vein Occlusion Study, an extension study of the BRAVO Study, found that long-term multiple intravitreal injections of ranibizumab were well-tolerated by patients with branch retinal vein occlusion and central retinal vein occlusion.
For corneal researchers, gaining access to any sizable amount of high quality tissue has long been a challenge.
Six years after OSI Pharmaceuticals Inc. bought Eyetech Pharmaceuticals Inc. for $650 million on the promise of its treatment for wet age-related macular degeneration, Valeant Pharmaceuticals International Inc. has announced it will acquire Eyetech for $22 million.
Ophthalmologists using a proprietary confocal scanning laser ophthalmoscope with a fundus autofluorescence module can now quantify and track progression of geographic atrophy over time, thanks to the release of new software.
Results from an integrated analysis of data from 12 months of follow-up in the two similarly designed prospective, randomized studies comparing aflibercept and ranibizumab indicate that intravitreal injection of aflibercept every 2 months is safe, predictably effective therapy for neovascular age-related macular degeneration and comparable to monthly ranibizumab 0.5 mg.
The results of the direct comparison of ranibizumab and bevacizumab after 1 year of treatment showed that the two drugs adminisred according to monthly and as-needed protocols produced significant decreases in retinal fluid with small amounts of residual fluid in patients with AMD.
The use of laser to treat diabetic macular edema is often the topic of debate.
A multicolor pattern scan laser should help laser therapy maintain or potentially expand its role in the treatment of certain retinal diseases even with the availability of effective new injectable pharmaceutical products, according to retinal specialists.
New software (version 6.0) introduced for a proprietary high-definition ocular coherence tomography platform provides researchers and clinicians an expanded set of diagnostic tools to use in the evaluation and management of patients with AMD and glaucoma.
On Feb. 13, Merck announced that it received approval from the FDA to market its one-of-a-kind, preservative-free, prostaglandin analog, tafluprost ophthalmic solution 0.0015%, for lowering IOP in patients with open-angle glaucoma or ocular hypertension.
Ocriplasmin can eliminate the need for surgery to close macular holes in a substantial percentage of patients.
On Jan. 30, vismodegib became the first drug approved by the FDA for the treatment of advanced basal cell carcinoma.
Loteprednol etabonate ophthalmic suspension 0.2% is a safe and effective first-line therapy for the treatment of seasonal and perennial allergic conjunctivitis.
Use of spectacles, contact lenses, or medications does not inhibit the progression of myopia for any length of time, as seen in in large major studies in children.
Doing the best possible job for patients with ocular allergies involves a careful ferreting out of symptoms and selecting the most effective treatments based on the severity of the disease and the effectiveness of the medications.
Analysis of data from two bilateral conjunctival allergen challenge studies of olopatadine hydrochloride ophthalmic solution 0.2% showed that ocular itching was prevented in a higher percentage of eyes treated with olopatadine when compared with vehicle.
Therapy for ocular allergy has shown significant progress in recent years.
Recent findings about uveal melanoma indicate that patients can be divided into high- and low-risk clasess, and that a mutation in one gene on chromosomes 3, BAP1, is closely associated with the high metastatic risk class 2 form of uveal melanoma.
Since the 2009 approval of bepotastine besilate ophthalmic solution 1.5% for ophthalmic use in the United States, further analysis of clinical trial data and new information from additional studies have revealed more about the drug's clinical utility.
Variety may be the key to selling sunwear successfully in your practice.
Ophthalmologists are not formally trained in the art of talking with patients about potentially stressful medical diagnoses; yet, this skill is important and can be the most challenging part of practice for glaucoma specialists.
Severe halos/glare was the issue most feared most by surgeons implanting diffractive multifocal IOLs, according to a survey.
In the movies "The Da Vinci Code" and "The Matrix Reloaded," evil gunmen who are albinos figure prominently.
When it comes to sunwear, frames get most of the attention.
The trabecular meshwork fails in glaucoma because of physical changes in the trabecular meshwork and altered signaling pathways.
